Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**MOB kinase activator 3A** is a protein-coding gene that encodes a protein believed to serve as a regulator of kinases, most notably functioning as a protein kinase activator[1][5][7]. It is involved in signal transduction and is predicted to operate in both the cytoplasm and nucleus[1][4][6][7]. The gene is a member of the MOB kinase activator family, sharing similarity with other MOB proteins, and its biological role involves acting upstream in phosphorylation pathways[1][2][4]. Diseases associated with mutations or dysregulation of MOB3A include lung occult small cell carcinoma, with further research needed to clarify broader clinical relevance[1]. No approved drugs or established clinical biomarkers specifically target MOB3A, and it is not considered a canonical therapeutic target at this time, though it remains of research interest for its role in kinase regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MOB kinase activator 3A (MOB3A).